APEX GLOBAL TRADES Review
25
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | September 2025 | 0 |
| October 2025 | 0 | |
| November 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About APEX GLOBAL TRADES
APEX GLOBAL TRADES is not authorised by the UK Financial Conduct Authority and has been explicitly flagged in an FCA warning published on 18 October 2024, which states the firm “may be providing or promoting financial services or products without our permission”; the published details include the name APEX‑GLOBAL TRADES / APEX GLOBAL TRADES, address 55‑61 High Street, Eltham, United Kingdom, SE9 1TD, email support@apex-globaltrades.com, and website https://apex-globaltrades.com/ ().
The firm is not regulated by any recognised financial authority; claims of regulation via Companies House are misleading, as Companies House has no authority over forex or financial services regulation (). The website appears to use a generic template associated with scam operations, and independent reports highlight issues including difficulty withdrawing funds, aggressive marketing tactics, and anonymous ownership ().
Pros and cons
Pros
- No verifiable licensing or regulation confirms that funds are unprotected.
Cons
- Unauthorised by FCA; subject of formal warning ().
- No recognised regulatory oversight; claims of Companies House regulation are invalid ().
- Website employs generic “scam” template; ownership is anonymous ().
- Reports of withdrawal difficulties, aggressive sales tactics, and misleading promises ().
Who it’s for
- Investors should avoid APEX GLOBAL TRADES entirely due to the lack of regulation and formal warning from a major regulator.
- No responsible investor profile can be supported given these evidence-based concerns.
Official source for regulatory warning: .
